|
September 27, 2023
|
Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer
|
|
|
August 29, 2023
|
Caribou Biosciences to Participate in Upcoming Investor Conferences
|
|
|
August 8, 2023
|
Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update
|
|
|
July 13, 2023
|
Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering
|
|
|
July 13, 2023
|
Caribou Biosciences Announces Proposed Public Offering of Common Stock
|
|
|
July 13, 2023
|
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
|
|
|
July 6, 2023
|
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
|
|
|
May 31, 2023
|
Caribou Biosciences to Participate in Upcoming Investor Conferences
|
|
|
May 9, 2023
|
Caribou Biosciences Reports First Quarter 2023 Financial Results and Provides Business Update
|
|
|
May 8, 2023
|
Caribou Biosciences Announces Appointment of Stephen J. Schuster, MD, to its Scientific Advisory Board
|
|
